Saturday 17 October 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024. In the quarter to June 2026, revenue fell 97.6%, EPS fell 800.0%, free cash flow fell 154.1% and total debt fell 8.32%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

1.52 0.13 −7.88%

Follow LXRX

Alert me

Market cap: $734.2M
P/E: 0.0×
Fwd P/E: −12.1×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	4	4	4	+8 more TTM periods Free account
ROE Full definition →	(40.21%)	(16.01%)	(39.72%)	(45.92%)
ROA Full definition →	(25.70%)	(9.21%)	(20.83%)	(26.02%)
ROIC Full definition →	(96.36%)	(18.49%)	(46.81%)	(68.83%)
Return on Tangible Assets Full definition →	(33.30%)	(14.67%)	(60.73%)	(66.72%)
Average Days of Receivables Full definition →	14.46	61.73	17.47	12.02
Free Cash Flow per Share Full definition →	(0.15)	(0.10)	(0.19)	(0.20)
Free Cash Flow Full definition →	(64.99)	(38.80)	(67.85)	(72.11)
Other line items
Cash ROIC Full definition →	(15.60%)	(9.17%)	(26.32%)	(24.64%)
Accounts Receivable Turnover Full definition →	21.68	2.35	17.01	27.10
Accounts Payable Turnover Full definition →	0.09	0.05	0.03	0.05
Inventory Turnover Full definition →	0.52	1.48	1.07	1.06
Average Days of Payables Full definition →	2,388.81	3,106.65	4,106.92	3,291.94
Days of Inventory on Hand Full definition →	1,219.39	286.19	374.32	136.98
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	145.34%	84.11%	122.73%	107.94%
Selling, General and Administrative Expense of Revenue Full definition →	85.23%	50.18%	74.93%	85.82%
Share Based Compensation of Revenue Full definition →	30.61%	18.02%	25.13%	15.83%
Interest Coverage Full definition →	(6.50)	(2.99)	(5.87)	(6.58)
Operating CF/Net income Full definition →	1.06	1.49	1.35	1.05
Depreciation/Fixed assets Full definition →	1.57	1.45	1.25	1.13
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.09	0.17	0.14	0.20
Operating CF per Share Full definition →	(0.15)	(0.10)	(0.19)	(0.20)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly